GovChime
Notice ID: 43903743ad5846509f2dff8eaf775626PresolicitationArchived

GENOTYPING AND GENETIC MONITORING OF MOUSE SAMPLES.

Archived on January 26, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM EST
Posted
January 16, 2026
Notice type
Presolicitation
NAICS
541380: Testing Laboratories and Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIAID
Place of performance
Maryland
Last updated
Nov 4, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
NIAID-NOI-26-2279499
Notice ID
43903743ad5846509f2dff8eaf775626

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Transnetyx Inc to purchase mouse genotyping services. These items are for a number of ongoing NIAID DIR projects. Multiple DIR laboratories breed transgenic mice and produce mouse samples that need to be tested regularly to determine proper genotype of the mice. Genotyping tests are needed regularly and accurately to ensure the new DNA is properly introduced to mice that are of importance for research of current infectious human diseases and various as animal models of human diseases. Transnetyx has existing TAGCenters found on the NIH Bethesda Campus with multiple drop boxes for sample collection and provides free weekly shipping. Using the existing automated TAGCenters allows for scheduled time for shipping and pickup time convenience for the Investigators for dropping off samples. Also, Transnetyx’s TAGCenters provides FedEx tracking time stamp tracking and audit trail in four labs with multiple shippers. Finally, Transnetyx provides a secured website to allow for the Investigators to login and access the rapidly processed and produced genotyping data securely and provides backup of all data collected. Because of the unique nature of the existing setup and the multiple locations of the TAGCenters around the Bethesda Campus no other company can provide this genotyping service with this level of rapidity and convenience at a lower cost for the DIR Investigators.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (2)

  • AMBIS 2279499 - NOI.pdf

    67 KBAdded in Presolicitation version 3Posted
    Download
  • AMBIS 2279499 - SOW.pdf

    118 KBAdded in Presolicitation version 3Posted
    Download

Lifecycle

  1. 3
    Version 3PresolicitationArchivedCurrent

    GENOTYPING AND GENETIC MONITORING OF MOUSE SAMPLES.

    Notice 43903743ad5846509f2dff8eaf775626 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Quotations are being requested and a separate written solicitation will not be issued. Solicitation number 124PSA27Q0017 is issued as a Request for Quotation (RFQ) for Proficiency Samples to the Field Service Laboratories (FSL) for all FSIS labs. This acquisition is set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 541380 - Testing Laboratories and Services. The small business size standard is $19M. This acquisition is a Total Small Business Set-Aside. All responsible sources may submit a quotation which will be considered by the agency.
66%
Combined Synopsis12/12/2026
General Information Document Type: Presolicitation Synopsis Number: 75N98027Q00086 Posted Date: November 16, 2026 Original Response Date: November 26, 2026 Current Response Date: November 26, 2026 Set Aside: N/A NAICS Code: 541380 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Eminent Services Corp 7495 New Technology WAY Frederick, Maryland 21703 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541380 with a Size Standard $19,000,000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Storage and monitoring of ManNac for FDA regulations Background Information: Under this task order, the contractor will independently provide support services to satisfy the overall operational objectives of the National Human Genome Research Institute (NHGRI). The refrigerated storage of the clinical grade drug-in-sachet needs to be conducted under strict temperature control and FDA-regulatory requirements. NHGRI wants to contract a company for long-term refrigerated storage of a large batch of our unlabeled investigational drug N-acetylmannosamine (ManNAc), the drug is packaged as powder-in-sachets and stored in 16 boxes (8x12x14’’box dimensions) and contain 600 sachets/box. NHGRI plans to use this drug in future clinical trials of ManNAc for other indications, such as GNE-related thrombocytopenia or nephrotic disease. NHGRI anticipates storing this batch of unlabeled drug at a company for a period of up to 2 years. The refrigerated storage of the clinical grade drug-in-sachet needs to be conducted under strict temperature control and FDA-regulatory requirements. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by November 26, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98027Q00086. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”
56%
Pre-Solicitation11/26/2026
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for ACL TOP 750 Analyzers kits and reagents used in patient care testing. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.500 This subpart authorizes the use of simplified procedures for the acquisition of supplies and services in amounts greater than the simplified acquisition threshold but not exceeding $9 million ($15 million for acquisitions as described in 13.500(c)), including options, if the contracting officer reasonably expects, based on the nature of the supplies or services sought, and on market research, that offers will include only commercial products or commercial services. Contracting officers may use any simplified acquisition procedure in this part, subject to any specific dollar limitation applicable to the particular procedure. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date. Notice Type: Notice of Intent NAICS Code: 541380 PSC Code: J066 Posted Date: 11/16/2026 Close Date: 11/27/2026 12pm EST End User IC: Clinical Center POC Name: Ryssa Nix Email Address: Ryssa.nix@nih.gov
46%
Pre-Solicitation11/27/2026
THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a solicitation will not receive a response. Responses to this sources sought must be in writing. The purpose of this sources sought announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Small Businesses interested and capable of providing the services described below. NIH-OD-SS-27-000058 The information gained from this market research will help the National Institutes (NIH) Clinical Center (CC) plan for its acquisition strategy. Potential Large and Small Businesses shall include business information outlined in the section below as a part of their response. Complete responses to this notice shall be in the following format: SAM UEI Number and CAGE code Company Name Company Address, City, State and Zip Code Company Point of Contact, Email Address and Telephone Number Current GSA Schedule appropriate to this Sources Sought of other FAR Part 8 considerations Socioeconomic Status: (i.e., HUBZone, 8a, Small Business, Women Owned Small Business, Veteran-Owned Small-Business, etc.) https://www.sam.gov. Provide a capability statement that addresses the organizations qualifications and ability to perform as a contractor for the work described in the Statement of Work. The NIH Clinical Center Office of Research Support and Compliance (ORSC) is seeking a qualified and experienced contractor to provide project management and coordination of routine and emergent qualification, calibration/PM and certification services, including repairs and replacements, for the departments/ICs located at the NIH’s Bethesda, MD campus. Please see attached SOW for more details. Contractors shall not reach out to the customer for any questions or clarifications. All communications must go through contracting. ****************************************************************************** Important information: The Government is not obligated to nor will it pay for or reimburse any costs associated with responding to this source sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. NAICS: The North American Classification System (NAICS) code for this acquisition is 541380. PSC: H966 Notice to potential offerors: All offerors who provide goods or services to the United States Federal Government must be registered and have an active registration in the System for Award Management (SAM) at www.sam.gov and complete Online Representations and Certifications Application (ORCA). All interested Offerors should submit information by e-mail to ryssa.nix@nih.gov. Please use subject line “Response to NIH-OD-SS-27-000058”. All information submissions shall be received no later than noon on November 15, 2026.
46%
Pre-Solicitation11/15/2026
INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Alcami Corporation 2320 Scientific Park DR Wilmington, North Carolina 28405-1800 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541380 with a Size Standard $16.6M. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance Background Information: NHGRI was gifted 48kg of unlabeled drug ManNAc (powder-in-sachet) in September 2025, and agreed to take over the FDA-required, mandatory, stability testing program of this drug that has been ongoing at Alcami Corporation since June 2024. The gifted drug was produced in 2 campaigns, Campaign 5 (C5, June 2024) and Campaign 6 (C6, September 2024). NHGRI plans to use the donated clinical grade drug for upcoming clinical trials. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by November 9, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98027Q00040. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”
46%
Pre-Solicitation11/09/2026

Additional Details

Solicitation Number

NIAID-NOI-26-2279499

Archive Date

Jan 26, 2026

Office Address

BETHESDA, MD, 20892